This is not a lost patient
They exemplify how a financialized business model that uses patents as a key tool to maximize profits and shareholder enrichment deepens structural health inequities
Selected drug candidates from each of the two pipelines are mentioned below
Over the past few years, litigation has focused on a wide range of issues including patent and other IP disputes, product liability, regulatory challenges, importation concerns, and legal issues concerning the availability of compounded versions of GLP-1 drugs in view of the U.S
Accin cosmtica: -Manchas faciales
Compounded via telehealth: Online platforms like ShedRx run a 5-minute health questionnaire, route to a licensed clinician, and ship from a partner 503A pharmacy